There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

CARERS Act of 2017
Compassionate Access, Research Expansion, and Respect States Act of 2017

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To extend the principle of federalism to State drug policy, provide access to medical marijuana, and enable research into the medicinal properties of marijuana.


Actions Overview (1)

Date
06/15/2017Introduced in House

All Actions (9)

Date
06/16/2017Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
06/15/2017Referred to the Subcommittee on Health.
Action By: Committee on Veterans' Affairs
06/15/2017Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Action By: Committee on the Judiciary
06/15/2017Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
06/15/2017Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
06/15/2017Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
06/15/2017Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
06/15/2017Sponsor introductory remarks on measure. (CR E834)
Action By: House of Representatives
06/15/2017Introduced in House
Action By: House of Representatives

Committees (3)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce06/15/2017 Referred to
House Energy and Commerce Subcommittee on Health06/16/2017 Referred to
House Judiciary06/15/2017 Referred to
House Judiciary Subcommittee on Crime, Terrorism, Homeland Security, and Investigations06/15/2017 Referred to
House Veterans' Affairs06/15/2017 Referred to
House Veterans' Affairs Subcommittee on Health06/15/2017 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (1)

There is one summary for H.R.2920. View summaries

Shown Here:
Introduced in House (06/15/2017)

Compassionate Access, Research Expansion, and Respect States Act of 2017 or the CARERS Act of 2017

This bill amends the Controlled Substances Act to provide that the Act's regulatory controls and administrative, civil, and criminal penalties do not apply to a person who produces, possesses, distributes, dispenses, administers, tests, recommends, or delivers medical marijuana in compliance with state law.

The bill also:

  • excludes "cannabidiol" (CBD) from the definition of "marijuana";
  • limits the concentration of delta-9-tetrahydrocannabinol (THC) in CBD to 0.3 percent on a dry weight basis; and
  • deems marijuana grown or processed to make CBD, in accordance with state law, to comply with the THC concentration limit unless the Drug Enforcement Administration (DEA) determines state law to be unreasonable.

The bill directs the Department of Health and Human Services (HHS) to terminate the Public Health Service's interdisciplinary review process that is used to evaluate applications for medical marijuana research. The DEA must license manufacturers and distributors of marijuana for medical research; HHS must register practitioners to conduct research; and the Department of Veterans Affairs (VA) must authorize VA health care providers to provide recommendations and opinions to veterans regarding participation in their states' marijuana programs.